Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg et al. · New England Journal of Medicine · 1994 · 3.8K citations · Full text

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

Jaime L. Masferrer, Ben S. Zweifel, Pamela T. Manning et al. · Proceedings of the National Academy of Sciences · 1994 · 1.3K citations · Full text

Inflammation, Molecular Pharmacology, Selective Inhibition +14

Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

A.P. Adamis, Joan W. Miller, Teresa Bernal et al. · American Journal of Ophthalmology · 1994 · 1.3K citations

Diabetic Retinopathy, Ocular Disease, Proliferative Diabetic Retinopathy +7

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Lloyd Paul Aiello, Eric A. Pierce, E D Foley et al. · Proceedings of the National Academy of Sciences · 1995 · 1.3K citations · Full text

Pharmacological analysis of cyclooxygenase-1 in inflammation

Chris Smith, Yan Zhang, Carol M. Koboldt et al. · Proceedings of the National Academy of Sciences · 1998 · 808 citations · Full text

Inflammation, Anti-inflammatory, Cox-2-derived Pgs +15